There are approximately 1.6M cancer survivors across Canada, and there are more people entering the survivorship phase than ever before.

The Transition Study focuses on cancer survivors who completed their primary cancer treatment in the last one to three years. This includes: adults 30 years of age and older diagnosed with non-metastatic breast, prostate, colorectal, hematological cancers, or melanoma; and adolescents and young adults (18 to 29 years of age) diagnosed with any form of non-metastatic cancer and metastatic testicular cancer.

  • Working with provincial cancer registries, over 40,000 individuals who met the inclusion criteria were invited to participate.
  • Overall, we had a 33% response rate, giving us a total of 13,258 respondents from all 10 provinces, which provides a truly robust sample that will shed light on important insights as a country.
  • The survey implementation was undertaken between June 13th 2016- October 28th 2016

The study provides foundational information about the experience of cancer survivors following completion of their cancer treatment to identify opportunities to drive system improvements and enhance the quality of life of those affected by cancer.

Insights from this study are available below.

Insights